IceCure Medical (ICCM)
(Delayed Data from NSDQ)
$0.69 USD
-0.03 (-3.82%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $0.67 -0.02 (-2.90%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Price, Consensus and EPS Surprise
ICCM 0.69 -0.03(-3.82%)
Will ICCM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ICCM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ICCM
IceCure Medical Ltd. (ICCM) Reports Q2 Loss, Tops Revenue Estimates
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates
ICCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
GoodRx Holdings, Inc. (GDRX) Misses Q2 Earnings and Revenue Estimates
Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates
Progyny (PGNY) Beats Q2 Earnings Estimates
Other News for ICCM
ICCM Stock Earnings: Icecure Medical Beats EPS, Beats Revenue for Q2 2024
IceCure Medical Reports 20% Growth in ProSense? System and Probe Sales for the First Half of 2024; Reflects Continued Adoption in the U.S. and Other Global Markets
IceCure Medical GAAP EPS of -$0.14 misses by $0.07, revenue of $1.75M beats by $0.82M
IceCure Medical Ltd (ICCM) Q2 2024 Earnings Call Transcript
IceCure's ProSense? Destroyed 100% of Breast Cancer Tumors in Independent Study of Patients Who Chose Cryoablation Instead of Surgery